The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of the combination of cisplatin plus nab-paclitaxel and nivolumab with radiotherapy after maximal tumor resection in non-metastatic muscle invasive bladder cancer (CNN-BC trial).
 
Chiara Ciccarese
No Relationships to Disclose
 
Roberto Iacovelli
Honoraria - Astellas Pharma; IPSEN; MSD; Pfizer
Consulting or Advisory Role - AAA/Endocyte/Novartis; Astellas Pharma; Bayer; Eisai; Janssen; Merck; MSD; Novartis; Pfizer; Sanofi
Speakers' Bureau - Ipsen; Janssen; MSD; Pfizer; Sanofi
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen; MSD; Pfizer
 
Anna Rita Alitto
Consulting or Advisory Role - Janssen Oncology
 
Annunziato Anghelone
No Relationships to Disclose
 
Ileana Sparagna
No Relationships to Disclose
 
Luca Tagliaferri
Honoraria - Elekta; Nanobiotix; Novartis; Sanofi; Sun Pharma
Consulting or Advisory Role - Nanobiotix; Novartis; Sanofi
Speakers' Bureau - Sanofi; Sun Pharma
Patents, Royalties, Other Intellectual Property - Book
 
Giuseppe Palermo
No Relationships to Disclose
 
Marco Racioppi
No Relationships to Disclose
 
Giampaolo Tortora
No Relationships to Disclose